WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 12'4601 Infant (under 12 months) mortality rate: 112
GDP / capita (US$): 20'3231 Child (under 5 years) mortality rate: 132

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 43'847  43'418  42'982  42'540  42'097  37'057  32'730  28'106 
Births 753  754  754  754  753  720  714  692 
Surviving infants 743  744  744  744  742  707  696  667 
Pop. less than 5 years 3'736  3'718  3'705  3'681  3'655  3'472  3'415  3'317 
Pop. less than 15 years 10'988  10'940  10'895  10'834  10'765  10'370  10'020  8'524 
Female 15-49 years 10'909  10'804  10'701  10'601  10'502  9'192  7'820  6'753 

Number of reported cases

(Click for retrospective incidence data for Argentina)
Diphtheria
ChartChart
  31  86 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  1'967  16'102 
Mumps
ChartChart
  74  156  87  3'772  4'619 
Pertussis
ChartChart
  1'686  975  561  1'112  1'239  515  2'012  27'223 
Polio*
ChartChart
  32 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  10  11  10  12  49  219 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Argentina)
Vaccine year result method % card seen                                                
BCG          92  99*  99*  99*  99*  71  99*  62 
DTP1          88  94  98  94  94  88 
DTP3          92  94  94  94  91  83  87  44 
DTP4          79  74  84 
IPV1          56 
HepB_BD          81  84  87  85  88 
HepB3          92  94  94  94  91 
Hib3          92  94  94  94  91  83 
JapEnc         
MCV1          90  89  95  94  94  91  93  61 
MCV2          88  87  96  99*  89  56 
MenA         
PCV1          88  92  99  98  69 
PCV2          84  87  93  90  48 
PCV3          82  82  89  86  41 
Pol3          87  93  92  90  90  88  90  33 
Rota1          85  83 
RotaC          75  61 
RCV1          90  89  95  94  94 
TT2plus 2011  43  MICS     82  62  95  78 
PAB         
VAD1         
YFV          72  60  51  91  89 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Argentina)
BCG
ChartChart
  92  96  99  99  99  95  99  62 
DTP1
ChartChart
  97  94  98  94  94  96  95  69 
DTP3
ChartChart
  92  94  94  94  91  83  87  44 
HepB3
ChartChart
  92  94  94  94  91 
HepB_BD
ChartChart
  81  84  87  85  88 
Hib3
ChartChart
  92  94  94  94  91  83 
IPV1
  56 
MCV1
ChartChart
  90  89  95  94  94  91  93  61 
MCV2
ChartChart
  88  87  96  83  89  56 
PCV3
ChartChart
  82  82  89  86  41 
Pol3
ChartChart
  87  93  92  90  90  88  90  33 
RCV1
ChartChart
  90  89  95  94  94  91 
RotaC
ChartChart
  75  61 
YFV
ChartChart
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 512  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 65
From 80 to 89% 13
From 50 to 79% 13
Less than 50% 9
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Birth; Yes
CHOLERA Yes militaries
DTwP 6 years; Yes
DTwPHibHepB 2, 4, 6, 15-18 months; Yes
HepA_Pediatric 12 months; Yes
HepB_Adult Yes
HepB_Pediatric birth; Yes
HIB Yes special groups
HPV 11 years (x2); Yes
Influenza_Adult => 65 years; Yes and adults with chronic diseases, pregnant women, health care workers and other risk groups
Influenza_Pediatric 6-24 months; Yes and children with chronic diseases
IPV 2 months; Yes
MMR 1, 6 years; Yes and Y11 if not yet vaccinated
OPV 4, 6, 15-18 months; 6 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps > 65 years; Yes and risk groups
Rotavirus 2, 4 months; Yes
Td Yes adults every 10 years
Tdap 11 years; Yes HCW and PW
Varicella 15 months; Yes
YF 18 months; No Risk areas and travelers

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2016  2011-2016  2011-2016  2011-2016  2010-2015  2012-2016  2010-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 12    24  24  129   

System performance

Total Nº districts in country number 512  511  511  511  511    511 
Nº districts with DTP3 coverage >=80% number 400  459  440  452  430  381  349 
% of districts with DTP3 coverage >=80% From 0 to 100% 78  90  86  88  84    68 
Nº districts with measles (MCV1) coverage >=95% number 234  264  286  295  270  254  259 
% of districts with MCV1 coverage >=95% From 0 to 100% 46  52  56  58  53    51 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  60  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.